This inventor holds 1 USPTO granted patent. Top assignee: Sanford Burnham Prebys Medical Discovery Institute. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yohei Kiyotsuka: Innovator in Ectonucleotide Modulation
Introduction
Yohei Kiyotsuka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of small molecule modulators.
Latest Patents
Kiyotsuka holds a patent for "Substituted pyrazolo[3,4-b]pyridines as ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) modulators." This patent includes small molecule modulators of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), compositions comprising the compounds of Formula (XI), and methods of using these compounds and compositions. He has 1 patent to his name.
Career Highlights
Kiyotsuka is affiliated with the Sanford Burnham Prebys Medical Discovery Institute, where he conducts research aimed at advancing medical science. His work focuses on the modulation of enzymes that play critical roles in various biological processes.
Conclusion
Yohei Kiyotsuka is a notable inventor whose work in ectonucleotide modulation has the potential to impact therapeutic strategies. His contributions to the field are significant and reflect his dedication to advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile